Mucosal (oral and vulval) lichen planus in women: Are angiotensin- converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition?: Clinical dermatology • Original article

Clinical and Experimental Dermatology

Volumn 35, Issue 4, 2010, Pages 384-387

  Clayton, R ^a,d   Chaudhry, S ^b   Ali, I ^c   Cooper, S ^c   Hodgson, T ^b   Wojnarowska, F ^c  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d AMERSHAM HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG USE; FEMALE; HUMAN; LICHEN PLANUS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; ONSET AGE; PATIENT ASSESSMENT; POPULATION RISK; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ERUPTIONS; FEMALE; HUMANS; LICHEN PLANUS; LICHEN PLANUS, ORAL; MIDDLE AGED; RETROSPECTIVE STUDIES; VULVAR DISEASES;

EID: 77951241270     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03581.x     Document Type: Article

References (13)

1. Strauss RA, Rattore L, Soltani K. The association of mucocutaneous lichen planus and chronic liver disease. Oral Surg Oral Med Oral Pathol 1989 68 : 406 410. (Pubitemid 19254440)
2. Micheletti L, Preti M, Bogliatto F et al. Vulval lichen planus in the practice of a vulval clinic. Br J Dermatol 2000 143 : 1349 1350. (Pubitemid 32052801)
3. Lewis FM, Shah M, Harrington CI. Vulval involvement in lichen planus: a study of 37 women. Br J Dermatol 1996 136 : 89 91. (Pubitemid 26225122)
4. Potts AJC, Hamburger J, Scully C. The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 1987 64 : 541 543.
5. Robertson WD, Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 1992 74 : 183 185.
6. Firth N, Reade PC. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. Oral Surg Oral Med Oral Pathol 1989 67 : 41 4. (Pubitemid 19038937)
7. Reinhardt LA, Wilkin JK, Kirkendall WM. Lichenoid eruption produced by captopril. Cutis 1983 31 : 98 9.
8. Villaverde RR, Melguizo JB, Solano JL, Ortega SS. Lichen planus-like eruption due to enalapril. J Eur Acad Dermatol Venerol 2003 17 : 601 619.
9. Roten SV, Mainetti C, Donath R, Saurat JH. Enalapril-induced lichen planus-like eruption. J Am Acad Dermatol 1995 32 : 293 295.
10. Schindler R, Dinarello CA, Koch KM. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine 1995 7 : 526 533.
11. Fukuzawa M, Satoh J, Sagara M et al. Angiotensin converting enyme inhibitors suppress production of tumour necrosis factor-alpha in vitro and in vivo. Immunopharmacology 1997 36 : 49 55. (Pubitemid 27153477)
12. Constantinescu CS, Goodman DB, Ventura ES. Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells. Immunol Lett 1998 62 : 25 31. (Pubitemid 28277393)
13. Williams B, Poulter NR, Brown MJ et al. The BHS Guidelines Working Party. British Hypertension Society Guidelines for Hypertension Management 2004 - BHS IV: Summary. BMJ 2004 328 : 634 640. (Pubitemid 38425770)